Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Johnson & Johnson vs. Eli Lilly: Which Healthcare Giant's Stock Is a Better Buy for 2027?

Key PointsJohnson & Johnson maintains a massive healthcare presence across both innovative medicines and advanced medical technologies.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

Reed’s: A Beloved Brand Standing on a Trapdoor

Controlled test markets let Reed's measure whether new products sell through before committing to a national launch, a test of its growth plan.

  • Reed's ginger beer, a beloved brand since the 1980s, faces uncertain future
  • Company seeks help, converting credit line into $9.25 million term loan
  • Interim CEO Neal Cohane focuses on adding retail doors and testing new products

More from Wednesday 11 November →